Abeona therapeutics announces leadership and board transitions

New york and cleveland, sept. 28, 2020 (globe newswire) -- abeona therapeutics inc. (nasdaq: abeo), a fully-integrated leader in gene and cell therapy, today announced changes in its executive leadership and board of directors. joÃo siffert, m.d. resigned from his positions as ceo, head of research and development, and chief medical officer, as well as member of the board of directors, on september 23, 2020. on september 27, 2020, brian pereira, m.d., stefano buono, stephen b. howell, m.d., george migausky and shawn tomasello each announced that they had stepped down from the board, effective immediately. no director gave any reason for their resignation and no director indicated any disagreements with the company.
ABEO Ratings Summary
ABEO Quant Ranking